- Home
- SM vs APGE Comparison
SM vs APGE Comparison
Compare SM & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SM | APGE |
|---|---|---|
| Founded | 1908 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 4.7B |
| IPO Year | 1996 | 2023 |
Fundamental Metrics
Financial Performance| Metric | SM | APGE |
|---|---|---|
| Price | $26.18 | $71.81 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 11 |
| Target Price | $32.57 | ★ $102.40 |
| AVG Volume (30 Days) | ★ 7.2M | 735.9K |
| Earning Date | 05-26-2026 | 01-01-0001 |
| Dividend Yield | ★ 3.14% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 5.64 | N/A |
| Revenue | ★ $3,154,000,000.00 | N/A |
| Revenue This Year | $126.07 | N/A |
| Revenue Next Year | $10.45 | N/A |
| P/E Ratio | $4.53 | ★ N/A |
| Revenue Growth | ★ 17.24 | N/A |
| 52 Week Low | $17.45 | $26.20 |
| 52 Week High | $32.26 | $84.56 |
Technical Indicators
Market Signals| Indicator | SM | APGE |
|---|---|---|
| Relative Strength Index (RSI) | 67.88 | 51.34 |
| Support Level | $25.10 | $35.24 |
| Resistance Level | $28.82 | $82.77 |
| Average True Range (ATR) | 1.21 | 3.87 |
| MACD | 0.10 | 0.46 |
| Stochastic Oscillator | 89.55 | 51.21 |
Price Performance
Historical ComparisonAbout SM SM Energy Company
SM Energy Co is an independent energy company engaged in the acquisition, exploration, development, and production of oil, gas, and NGLs in Texas and Utah. The Company operates in the oil and gas extraction industry, focused on exploration and production activities, onshore in the United States. Its portfolio is comprised of assets in the Midland Basin of West Texas, the Maverick Basin of South Texas, and the Uinta Basin of northeastern Utah.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.